Sinus CancerSymptoms, Doctors, Treatments, Advances & More
Sinus Cancer Overview
Learn About Sinus Cancer
MUSC Health ENT - Ben Sawyer
Rodney Schlosser is an Otolaryngologist practicing medicine in Mount Pleasant, South Carolina. Dr. Schlosser is rated as an Elite provider by MediFind in the treatment of Sinus Cancer. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Sinusitis, Chronic Rhinosinusitis with Nasal Polyps (CRSwNP), Nasal Polyps, Septoplasty, and Endoscopic Transnasal Transsphenoidal Surgery. Dr. Schlosser is currently accepting new patients.
Penn Pituitary Center
Nithin Adappa is an Otolaryngologist practicing medicine in Philadelphia, Pennsylvania. Dr. Adappa is rated as an Elite provider by MediFind in the treatment of Sinus Cancer. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Cerebrospinal Fluid Leak, Sinusitis, Sinus Cancer, Endoscopy, and Endoscopic Transnasal Transsphenoidal Surgery. Dr. Adappa is board certified in Otolaryngology, 2011. Dr. Adappa is currently accepting new patients.
Penn Pituitary Center
James Palmer is an Otolaryngologist practicing medicine in Philadelphia, Pennsylvania. Dr. Palmer is rated as an Elite provider by MediFind in the treatment of Sinus Cancer. He is also highly rated in 28 other conditions, according to our data. His clinical expertise encompasses Sinusitis, Cerebrospinal Fluid Leak, Chronic Rhinosinusitis with Nasal Polyps (CRSwNP), Endoscopy, and Endoscopic Transnasal Transsphenoidal Surgery. Dr. Palmer is board certified in Otolaryngology, 2001. Dr. Palmer is currently accepting new patients.
Summary: The aim of this research study is to evaluate the effectiveness and safety of a combination of immunotherapy, using a drug called toripalimab, with chemotherapy drugs, Carboplatin and Docetaxel, as a possible treatment before surgery for sinonasal cancers. The names of the study drugs used in this research study are: * Toripalimab (a type of monoclonal antibody) * Carboplatin (a type of antineopla...
Summary: This phase I/Ib trial tests the safety and best dose of ipatasertib in combination with the usual treatment approach using chemotherapy together with radiation therapy (chemo-radiation) in patients with head and neck cancer. Ipatasertib is in a class of medications called protein kinase B (AKT) inhibitors. It may stop the growth of tumor cells and may kill them. Cisplatin, which is a chemotherapy ...
